After microwave ablation of two percutaneous liver metastases, MRI shows no post‑contrast T1 enhancement in either lesion, but the larger lesion demonstrates restricted diffusion on diffusion‑weighted imaging (DWI). What does this indicate and how should it be managed?

Restricted Diffusion on DWI After Microwave Ablation: Likely Residual Viable Tumor Requiring Biopsy or Repeat Ablation

The larger lesion showing restricted diffusion on DWI despite absent T1 enhancement is highly concerning for residual viable tumor and warrants tissue confirmation via biopsy or consideration for repeat ablation.

Interpretation of Post-Ablation Imaging Findings

The Significance of Absent Enhancement

Lack of contrast enhancement (no enhancement on post-contrast T1 images) is considered the hallmark of successful ablation, occurring through disruption of tumor vascularity 1. Both lesions showing no enhancement is initially reassuring. However, this finding alone is insufficient to declare treatment success when other sequences suggest viable tissue.

The Critical Role of Restricted Diffusion

Restricted diffusion on DWI is a red flag for viable tumor tissue. While the evidence base is primarily from renal cell carcinoma ablation guidelines, the principles apply to liver metastases:

• Unenhanced T1-weighted sequences have the highest sensitivity (88-94%) for detecting local tumor progression after ablation 2
• DWI demonstrates high diagnostic confidence for detecting residual disease, with some studies showing 100% detection rates for recurrence 3
• The combination of DWI and hepatobiliary phase imaging allows correct classification of lesions as benign or malignant in 91% of cases 4

Why This Discordance Matters

The discordance between absent enhancement and restricted diffusion creates diagnostic uncertainty. Here's the algorithmic approach:

If DWI shows restricted diffusion:

• Viable tumor cells remain metabolically active (causing restricted diffusion)
• Vascular disruption may be incomplete or heterogeneous
• Enhancement may be temporarily suppressed but tumor viability persists

Common pitfalls to avoid:

• Do not rely solely on enhancement patterns in the immediate post-ablation period, as completely ablated lesions can show enhancement for weeks to months 1
• Do not dismiss restricted diffusion as "post-treatment change"—this represents cellular density and metabolic activity

Recommended Management Algorithm

Immediate Actions:

1. Correlate with ablation zone size: Measure the ablation zone on all sequences. Adequate margins should extend 5-10mm beyond the original tumor 5

2. Assess for specific features of residual disease:

   • Nodular or irregular areas of restricted diffusion at the periphery of the ablation zone
   • Progressive increase in size of the restricted diffusion area on serial imaging
   • Development of new enhancement in the treatment zone over time 1

Definitive Diagnosis:

Percutaneous biopsy should be strongly considered 1. The guidelines explicitly state: "The lack of spontaneous decline in enhancement and involution of the mass over time or the development of new areas of enhancement in the treatment zone...should raise concern for residual or recurrent disease. In these circumstances, a biopsy could be considered to identify the presence of viable neoplasm."

While this statement references enhancement, the same principle applies to persistent restricted diffusion, which indicates viable cellular tissue.

Alternative Approach:

If biopsy is not immediately feasible:

• Short-interval follow-up MRI at 4-6 weeks 5, 6
• Look for:
  • Progression of the restricted diffusion area
  • Development of enhancement
  • Lack of involution of the ablation zone
  • Any of these findings mandate biopsy or repeat ablation

Technical Considerations for PNET Liver Metastases

Pancreatic neuroendocrine tumor (PNET) metastases are typically hyperenhancing lesions due to their hypervascular nature 7. The absence of enhancement post-ablation is expected, but:

• PNETs can show variable enhancement patterns
• Microwave ablation creates a zone of coagulative necrosis that should be avascular
• The restricted diffusion suggests cellular viability that contradicts successful ablation

Specific Imaging Recommendations

For optimal follow-up of this patient:

1. MRI liver without and with IV contrast remains the gold standard 1, 8

   • Include DWI with high b-values (b=1000)
   • Obtain subtraction images (post-contrast minus pre-contrast) to better assess enhancement 1
   • Consider hepatobiliary contrast agent (gadoxetate) for improved lesion detection 7

2. Timing of follow-up imaging:

   • Initial post-ablation: within 24-48 hours (already done)
   • Next follow-up: 4-6 weeks 5, 6
   • Subsequent surveillance: every 3 months for the first year 5

Bottom Line

Do not wait for enhancement to develop. Restricted diffusion in the larger lesion represents a discordant finding that suggests incomplete ablation. The smaller lesion without restricted diffusion is likely successfully treated. Proceed with either immediate biopsy of the larger lesion or very short-interval (4-6 week) repeat MRI with the expectation that biopsy or repeat ablation will be necessary if restricted diffusion persists or progresses.

The stakes are high: early detection of residual disease allows for salvage ablation with curative intent, while delayed recognition may result in disease progression beyond salvageable stages.